Cancer Drugs in Development May Be Targeting Wrong Proteins
Cancer Drugs in Development May Be Targeting Wrong Proteins
A study of 11 drugs now in clinical trials suggests they do kill cancer cells—but through a different mechanism than indicated in previous research.
Cancer Drugs in Development May Be Targeting Wrong Proteins
Cancer Drugs in Development May Be Targeting Wrong Proteins

A study of 11 drugs now in clinical trials suggests they do kill cancer cells—but through a different mechanism than indicated in previous research.

A study of 11 drugs now in clinical trials suggests they do kill cancer cells—but through a different mechanism than indicated in previous research.

pharmacology
Image of the Day: Right on Target
Image of the Day: Right on Target
Nicoletta Lanese | Jul 23, 2019
An injectable biomaterial calls cancer drugs to tumor sites in mice.
How the Brain Changes on Ketamine: A Live Animal Study
How the Brain Changes on Ketamine: A Live Animal Study
Ruth Williams | Apr 11, 2019
The drug promotes and sustains brain cell connectivity in mice, reversing the effects of chronic stress.
Q&A: Anthony Fauci Describes an Experimental Ebola Treatment
Q&A: Anthony Fauci Describes an Experimental Ebola Treatment
Shawna Williams | Aug 14, 2018
The monoclonal antibody, known as mAb114, is likely to be used in the current Ebola outbreak in DRC.
Researchers Getting Smarter About Pairing Cancer Treatments
Researchers Getting Smarter About Pairing Cancer Treatments
Anna Azvolinsky | Apr 1, 2018
Multidrug combinations lead to better results for cancer patients, but efficiently identifying them is proving difficult.
Infographic: Cancer Drug Pairings
Infographic: Cancer Drug Pairings
Anna Azvolinsky | Mar 31, 2018
Researchers use several different strategies to deliver a one-two punch.
FDA Declares Kratom an Opioid. We’re Here to Explain What It Does.
FDA Declares Kratom an Opioid. We’re Here to Explain What It Does.
Jim Daley | Feb 7, 2018
The Scientist speaks with a clinical toxicologist to discuss how the supplement acts in the brain and what the agency's declaration means for research.
Nasser Zawia: An American Scientist Born in Yemen
Nasser Zawia: An American Scientist Born in Yemen
Bob Grant | Mar 23, 2017
The University of Rhode Island neurotoxicologist and dean came to the U.S. for college in the 1980s. 
Mystery Mechanisms
Mystery Mechanisms
Tanya Lewis | Jul 29, 2016
Scientists still don’t know exactly how some commonly used drugs work. Here’s a look at three such compounds.
Antibiotic Assistants
Antibiotic Assistants
Ruth Williams | Mar 9, 2016
Scientists discover compounds that restore antibiotic efficacy against drug-resistant superbugs.